Anti-Medical School Lecture


ShumanThe UC Berkeley – UC San Francisco
Master of Translational Medicine Program presents

the 1st Annual Marc Shuman Anti-Medical School Lecture

sponsored by the Grove Foundation

The Impact of Technology on Delivery of Medical Care in the 21st Century: A Panel Discussion


April 13, 2015
3:30 – 5:30 PM
Byers Auditorium, Genentech Hall, UCSF Mission Bay campus
Reception to follow. 

Please register at


Moderator: Ahmed Ghouri, MD
CEO and Founder, Interpreta Inc
John D. Halamka, MD, MS
Chief Information Officer and Dean for Technology, Harvard Medical School
John Mattison, MD
Chief Medical Information Officer, Kaiser Permanente
Roni Zeiger, MD
CEO, Smart Patients
former Chief Health Strategist, Google

Speaker Bios

John D. Halamka, MD, MS
Chief Information Officer and Dean for Technology, Harvard Medical School
John D. Halamka, MD, MS is Chief Information Officer of the Beth Israel Deaconess Medical Center, Chief Information Officer and Dean for Technology at Harvard Medical School, Chairman of the New England Health Electronic Data Interchange Network (NEHEN), CEO of MA-SHARE (the Regional Health Information Organization), Chair of the US Healthcare Information Technology Standards Panel (HITSP), and a practicing Emergency Physician.

Dr. Halamka completed his undergraduate studies at Stanford University where he received a degree in Medical Microbiology and a degree in Public Policy with a focus on technology issues. While at Stanford he served as research assistant to Dr. Edward Teller, Dr. Milton Friedman, and presidential candidate John B. Anderson. He authored three books on technology related issues and formed a software development firm, Ibis Research Labs, Inc.

In 1984, Dr. Halamka entered medical school at the University of California San Francisco and simultaneously pursued graduate work in Bioengineering at the University of California, Berkeley, focusing on technology issues in medicine. Dr. Halamka served his residency at Harbor-UCLA Medical Center in the Department of Emergency Medicine.

In 1996, Dr. Halamka joined the faculty of Harvard Medical School and continues to integrate his knowledge of medicine and technology focusing on the use of the Internet to exchange clinical patient data. His research includes security / confidentiality issues, scalability issues, and implementation of standards for exchange of administrative and clinical information. As a clinician as well as researcher, Dr. Halamka uses these tools to improve the care of the patients he treats in the Beth Israel Deaconess Emergency Department.

As Chief Information Officer at Beth Israel Deaconess, he is responsible for all clinical, financial, administrative and academic information technology serving 3,000 doctors, 12,000 employees and one million patients. As Chief Information Officer and Dean for Technology at Harvard Medical School, he oversees all educational, research and administrative computing for 18,000 faculty and 3,000 students.

As Chairman of NEHEN he oversees the administrative data exchange among the payors and providers in Massachusetts. As Chief Exchange Officer of MA-SHARE he oversees the Regional Healthcare Information Organization (RHIO), which develops clinical data exchange efforts in Massachusetts. As Chair of the US Healthcare Information Technology Standards Panel, he coordinates the process of electronic standards harmonization among stakeholders nationwide.

John Mattison MD
Chief Medical Information Officer, Kaiser Permanente
John Mattison currently oversees all information systems deployment in the Southern California region of Kaiser Permanente, which includes more than 5,000 physicians, 3 million members, 140 clinics, and 13 hospitals. He chairs the KP national IT Infrastructure governance group, the Regional Business Governance Group for all KP regions, and is a member of numerous other national governance groups including Security, and Care Delivery.

He led the KP HealthConnect project in Southern California, which has been fully implemented in every clinic and hospital, and represents the single largest deployment of a completely integrated electronic health record in the United States.

Dr. Mattison’s clinical background includes specialties of Internal Medicine and Critical Care. From 1984 to 1989 he practiced internal medicine and critical care at Scripps Clinic and Research Foundation, where he served as director of the Medical/Surgical Intensive Care Unit, and chaired committees on Pharmacy, Quality, and Utilization. In 1989 he began working for Kaiser Permanente in San Diego, where he practiced Critical Care and Primary Care in Internal Medicine. In 1992 he was appointed as Assistant Medical Director and Chief Medical Information Officer, and in 2003 became program director for the HealthConnect program.

Dr. Mattison has consulted internationally on health information technology and interoperability standards. He is the co-founder of the Clinical Document Architecture, which is the international standard for sharing patient records between institutions.

Roni Zeiger MD
CEO, Smart Patients
former Chief Health Strategist, Google
Roni is the former Chief Health Strategist at Google, where he led efforts ranging from Google Flu Trends to Symptom Search. In 2012, he co-founded Smart Patients, an online community where patients and caregivers affected by complex illness learn from each other about treatments, the latest science, and how it all fits into the context of their experience. Roni serves as CEO of Smart Patients and continues to see urgent care patients part time at Santa Clara Valley Medical Center, where he is a Community Staff Physician.

Roni earned his M.D. at Stanford University and completed his internal medicine residency at the University of California, San Francisco. He has served as a clinical instructor of medicine at Stanford University School of Medicine and received a master’s degree in biomedical informatics from Stanford.

Ahmed Ghouri MD (Moderator)
CEO and Founder, Interpreta
Dr. Ahmed Ghouri is the founder of Interpreta, a company developing a transformative Panoptical command-and-control system which intelligently evaluates all sources of patient data (EMR, insurer, and the whole genome) in real-time. Interpreta enables precision nano-diagnosis and treatment optimization, by considering the unique genetic composition and the longitudinal clinical history of a single patient, to drastically improve the quality of diagnosis, care, and outcomes.

Prior to founding Interpreta, Dr. Ghouri was the founder and Chief Executive Officer of Anvita, the highest performance clinical analytics company in healthcare, which computed two billion patient clinical data points per day, at a velocity of 3 million patients per hour. Anvita was acquired by the leading US insurer, Humana.

Dr. Ghouri is the principal author of 70+ peer reviewed scientific publications and eight granted US patents in analytics, medical devices, and software. He was a co-lead investigator leading to the FDA approval of two fundamentally new drugs flumazenil (the first benzodiazepine reversal drug) and desflurane (the first ultra-rapid general anesthetic). Dr. Ghouri received his M.D. degree from Washington University in St. Louis, where he also completed a biomedical engineering fellowship. He is a board-certified anesthesiologist.

About Marc Shuman, MD
UCSF Emeritus Professor of Medicine
His career has spanned laboratory research, teaching and patient care. He was funded by the NCI as an RO1 Principal Investigator for 30 years including a Program Project Grant focused on Proteases in Cancer and a Prostate Cancer SPORE. He has also been a co-investigator on several other extramural grants. He has held several leadership positions at the UCSF Comprehensive Cancer Center including Associate Director for Research and Education and Associate Director for Program Development, as well as the Executive Steering Committee and the Prostate Cancer Program leader. He has also served as Chief of the Adult Hematology & Oncology Division. Currently he serves as an Advisor for the UCSF Multiple Myeloma and Prostate Cancer Programs.

He contributed significantly to the development of the UCSF-UC-Berkeley Masters in Translational Medicine Program; he also leads an MTM required course and has initiated a new clinical elective for these graduate students.

Panel Topics

  • How will technology reshape medicine in the next 5 to 10 years? 
  • How will the human genome be used in routine clinical care in 5, 10 years?
  • How will big data (clinical AND genomic) help doctors make the best treatment- or non-treatment- decisions? The most accurate diagnoses? 
  • Will technology enhance a doctor’s intuition or replace it? How will we know?
  • How can technology LOWER the cost of getting new treatments to market? 
  • How can technology LOWER the daily costs of hospitalization?
  • How can technology dramatically improve the management of chronic diseases?